Skip to main content
Search

Peking University First Hospital

2 related articles

Subscribe to updates
  1. Diabetes

    Metabolomic clustering of 24,638 UK Biobank participants with prediabetes yields three subtypes with progressively higher type 2 diabetes, cardiovascular, and chronic kidney disease risk

    In 24,638 UK Biobank participants with prediabetes, LASSO and elastic net selection of nuclear magnetic resonance metabolomic markers yielded 16 biomarkers, and k-means clustering in the training set (12,322 participants) identified low-, intermediate-, and high-metabolic-risk subtypes that showed progressively higher risks of type 2 diabetes, cardiovascular disease, and chronic kidney disease in the validation set (12,316 participants), with diet-quality associations differing across subtypes and Mendelian randomization suggesting potential causal links for several metabolomic biomarkers.

  2. Review proposes a staged roadmap for digital twins in drug evaluation and flags practical and regulatory challenges

    This review states that, with improved computational resources and advances in artificial intelligence, current digital twins (DT) can integrate multi-omics data through hybrid mechanism- and data-driven models, enabling personalized simulation of patients, organs, and cells, which makes DT application in drug evaluation and drug repurposing discovery possible; the authors review current and emerging DT applications across the drug evaluation continuum, propose a staged development roadmap, and further highlight pivotal challenges that must be addressed to realize DT's full potential in drug evaluation, while noting that practical and regulatory issues have also emerged amid rapid development.

You’re all caught up